120 related articles for article (PubMed ID: 38197667)
21. The loss of RNA N
Dong L; Chen C; Zhang Y; Guo P; Wang Z; Li J; Liu Y; Liu J; Chang R; Li Y; Liang G; Lai W; Sun M; Dougherty U; Bissonnette MB; Wang H; Shen L; Xu MM; Han D
Cancer Cell; 2021 Jul; 39(7):945-957.e10. PubMed ID: 34019807
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of METTL14 mediates the elevation of PERP mRNA N
Wang M; Liu J; Zhao Y; He R; Xu X; Guo X; Li X; Xu S; Miao J; Guo J; Zhang H; Gong J; Zhu F; Tian R; Shi C; Peng F; Feng Y; Yu S; Xie Y; Jiang J; Li M; Wei W; He C; Qin R
Mol Cancer; 2020 Aug; 19(1):130. PubMed ID: 32843065
[TBL] [Abstract][Full Text] [Related]
23. N6-methyladenosine methyltransferase plays a role in hypoxic preconditioning partially through the interaction with lncRNA H19.
Su Y; Xu R; Zhang R; Qu Y; Zuo W; Ji Z; Geng H; Pan M; Ma G
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1306-1315. PubMed ID: 33197240
[TBL] [Abstract][Full Text] [Related]
24. METTL14 benefits the mesenchymal stem cells in patients with steroid-associated osteonecrosis of the femoral head by regulating the m6A level of PTPN6.
Cheng C; Zhang H; Zheng J; Jin Y; Wang D; Dai Z
Aging (Albany NY); 2021 Dec; 13(24):25903-25919. PubMed ID: 34910686
[TBL] [Abstract][Full Text] [Related]
25. RNA m6A methyltransferase METTL14 promotes the procession of non-small cell lung cancer by targeted CSF1R.
Ren S; Xiao Y; Yang L; Hu Y
Thorac Cancer; 2023 Jan; 14(3):254-266. PubMed ID: 36448247
[TBL] [Abstract][Full Text] [Related]
26. Mettl14-mediated m6A modification is essential for visual function and retinal photoreceptor survival.
Yang Y; Shuai P; Li X; Sun K; Jiang X; Liu W; Le W; Jiang H; Liu Y; Zhu X
BMC Biol; 2022 Jun; 20(1):140. PubMed ID: 35698136
[TBL] [Abstract][Full Text] [Related]
27. TCF4 and HuR mediated-METTL14 suppresses dissemination of colorectal cancer via N6-methyladenosine-dependent silencing of ARRDC4.
Wang H; Wei W; Zhang ZY; Liu Y; Shi B; Zhong W; Zhang HS; Fang X; Sun CL; Wang JB; Liu LX
Cell Death Dis; 2021 Dec; 13(1):3. PubMed ID: 34916487
[TBL] [Abstract][Full Text] [Related]
28. Methyltransferase-like (METTL)14-mediated N6-methyladenosine modification modulates retinal pigment epithelial (RPE) activity by regulating the methylation of microtubule-associated protein (MAP)2.
Yin L; Ma C; Hou S; Ma X
Bioengineered; 2022 Mar; 13(3):4773-4785. PubMed ID: 35139773
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer.
Ji H; Zhang JA; Liu H; Li K; Wang ZW; Zhu X
Front Immunol; 2022; 13():976107. PubMed ID: 36091006
[TBL] [Abstract][Full Text] [Related]
30. EBV epitranscriptome reprogramming by METTL14 is critical for viral-associated tumorigenesis.
Lang F; Singh RK; Pei Y; Zhang S; Sun K; Robertson ES
PLoS Pathog; 2019 Jun; 15(6):e1007796. PubMed ID: 31226160
[TBL] [Abstract][Full Text] [Related]
31. METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA.
Meng L; Lin H; Huang X; Weng J; Peng F; Wu S
Cell Death Dis; 2022 Jan; 13(1):38. PubMed ID: 35013106
[TBL] [Abstract][Full Text] [Related]
32. METTL14-mediated N6-methyladenosine modification of Pten mRNA inhibits tumour progression in clear-cell renal cell carcinoma.
Zhang L; Luo X; Qiao S
Br J Cancer; 2022 Jul; 127(1):30-42. PubMed ID: 35249103
[TBL] [Abstract][Full Text] [Related]
33. RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming.
Yin H; Zhang X; Yang P; Zhang X; Peng Y; Li D; Yu Y; Wu Y; Wang Y; Zhang J; Ding X; Wang X; Yang A; Zhang R
Nat Commun; 2021 Mar; 12(1):1394. PubMed ID: 33654093
[TBL] [Abstract][Full Text] [Related]
34. Recognition of G-quadruplex RNA by a crucial RNA methyltransferase component, METTL14.
Yoshida A; Oyoshi T; Suda A; Futaki S; Imanishi M
Nucleic Acids Res; 2022 Jan; 50(1):449-457. PubMed ID: 34908152
[TBL] [Abstract][Full Text] [Related]
35. The role, mechanism, and application of RNA methyltransferase METTL14 in gastrointestinal cancer.
Shi B; Liu WW; Yang K; Jiang GM; Wang H
Mol Cancer; 2022 Aug; 21(1):163. PubMed ID: 35974338
[TBL] [Abstract][Full Text] [Related]
36. METTL14 upregulates TCF1 through m6A mRNA methylation to stimulate osteogenic activity in osteoporosis.
Wang X; Zou C; Li M; Hou C; Jiang W; Bian Z; Zhu L
Hum Cell; 2023 Jan; 36(1):178-194. PubMed ID: 36401086
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
Condic M; Ralser DJ; Klümper N; Ellinger J; Qureischi M; Egger EK; Kristiansen G; Mustea A; Thiesler T
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806168
[TBL] [Abstract][Full Text] [Related]
38. METTL14 Regulates Osteogenesis of Bone Marrow Mesenchymal Stem Cells via Inducing Autophagy Through m6A/IGF2BPs/Beclin-1 Signal Axis.
He M; Lei H; He X; Liu Y; Wang A; Ren Z; Liu X; Yan G; Wang W; Wang Y; Li G; Wang T; Pu J; Shen Z; Wang Y; Xie J; Du W; Yuan Y; Yang L
Stem Cells Transl Med; 2022 Sep; 11(9):987-1001. PubMed ID: 35980318
[TBL] [Abstract][Full Text] [Related]
39. A cancer-associated METTL14 mutation induces aberrant m6A modification, affecting tumor growth.
Miyake K; Costa Cruz PH; Nagatomo I; Kato Y; Motooka D; Satoh S; Adachi Y; Takeda Y; Kawahara Y; Kumanogoh A
Cell Rep; 2023 Jul; 42(7):112688. PubMed ID: 37355987
[TBL] [Abstract][Full Text] [Related]
40. METTL14 promotes glomerular endothelial cell injury and diabetic nephropathy via m6A modification of α-klotho.
Li M; Deng L; Xu G
Mol Med; 2021 Sep; 27(1):106. PubMed ID: 34503454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]